Lindsay Machan, MD
Dr. Machan is an interventional radiologist at the Vancouver Hospital and Associate Professor of Radiology at the University of British Columbia. His professional interests include endovascular vein therapy and local therapy of restenosis. He is co-founder of Angiotech Pharmaceuticals, a company which developed and licensed the paclitaxel coated stent, and Ikomed Technologies which is developing methods for reducing radiation dose during fluoroscopy. Dr. Machan sits on many commercial and scientific advisory boards for medical companies across Canada and the U.S. As well as being an active angel investor, he is heavily involved as a clinical practitioner, researcher and teacher at Vancouver Hospital.